Disclosures for "Potential ASO-based Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"
-
Ms. Tyner has received personal compensation for serving as an employee of Vanda Pharmaceuticals Inc.. Ms. Tyner has stock in Vanda Pharmaceuticals Inc..
-
Dr. Smieszek has nothing to disclose.
-
-
Ms. Johnson has received personal compensation for serving as an employee of Vanda Pharmaceuticals Inc. Ms. Johnson has stock in Vanda Pharmaceuticals Inc.
-
Dr. Polymeropoulos has received personal compensation for serving as an employee of Vanda Pharmaceuticals Inc. An immediate family member of Dr. Polymeropoulos has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Vanda Pharmaceuticals Inc. Dr. Polymeropoulos has stock in Vanda Pharmaceuticals Inc.
-
Mr. Birznieks has received personal compensation for serving as an employee of Vanda Pharmaceuticals.
-
Dr. Polymeropoulos has received personal compensation for serving as an employee of Vanda Pharmaceuticals. Dr. Polymeropoulos has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Vanda Pharmaceuticals .